Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
Rchr
J-GLOBAL ID：201801013847092176
Update date: Jul. 17, 2024 Shumpei Ohnami
Shumpei Ohnami
- 2018 - 2021 An anticancer strategy of genes driven by KRAS-activating mutations
- 2011 - 2013 Global DNA methylation and genetic factors associated with folate metabolism on carcinogenesis in pancreatic cancer.
- Keiichi Ohshima, Takeshi Nagashima, Keiichi Fujiya, Keiichi Hatakeyama, Yuko Watanabe, Kimiko Morimoto, Fukumi Kamada, Yuji Shimoda, Sumiko Ohnami, Akane Naruoka, et al. Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations. Cancer research communications. 2023. 3. 4. 684-696
- Takeshi Nagashima, Kenichi Urakami, Yuji Shimoda, Keiichi Ohshima, Masakuni Serizawa, Keiichi Hatakeyama, Sumiko Ohnami, Shumpei Ohnami, Akane Naruoka, Yasue Horiuchi, et al. Comparative analysis of tumor content estimation methods based on simu- lated tumor samples identified their impact on somatic variant detection in cancer whole genome sequencing. Biomedical research (Tokyo, Japan). 2023. 44. 4. 161-171
- Keiichi Hatakeyama, Takeshi Nagashima, Keiichi Ohshima, Sumiko Ohnami, Shumpei Ohnami, Yuji Shimoda, Akane Naruoka, Koji Maruyama, Akira Iizuka, Tadashi Ashizawa, et al. Impact of somatic mutations and transcriptomic alterations on cancer aneuploidy. Biomedical research (Tokyo, Japan). 2023. 44. 5. 187-197
- Sumiko Ohnami, Akane Naruoka, Mitsuhiro Isaka, Maki Mizuguchi, Sou Nakatani, Fukumi Kamada, Yuji Shimoda, Ai Sakai, Keiichi Ohshima, Keiichi Hatakeyama, et al. Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes. Scientific reports. 2022. 12. 1. 17928-17928
- Yuji Shimoda, Takeshi Nagashima, Kenichi Urakami, Fukumi Kamada, Sou Nakatani, Maki Mizuguchi, Masakuni Serizawa, Keiichi Hatakeyama, Keiichi Ohshima, Tohru Mochizuki, et al. Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients. Biomedical research (Tokyo, Japan). 2022. 43. 4. 115-126
- Yuki Yamamoto, Naoko Goto, Shumpei Ohnami, Masatoshi Tagawa, Kazunori Aoki. A Cancer-Targeting Ligand Strongly Enhances Oncolytic Activity of a Conditionally Replicative Adenovirus. MOLECULAR THERAPY. 2013. 21. S245-S245
- Kazunori Aoki, Takeshi Nishimoto, Kimiko Yoshida, Shumpei Ohnami, Kaoru Kurisu, Teruhiko Yoshida. ONCOLYTIC VIRUS THERAPY FOR PANCREATIC CANCER USING AN ADENOVIRUS LIBRARY DISPLAYING RANDOM PEPTIDES ON THE FIBER KNOB. JOURNAL OF GENE MEDICINE. 2010. 12. 12. 1030-1031
- Kazunori Aoki, Kimiko Yoshida, Yoshiaki Miura, Kazuteru Hatanaka, Takeshi Nishimoto, Shumpei Ohnami, Teruhiko Yoshida. Direct selection of targeted vector from a random peptide library displayed on adenoviral fiber knob. JOURNAL OF GENE MEDICINE. 2006. 8. 12. 1467-1467
- Kazunori Aoki, Yoshiaki Miura, Kimiko Yoshida, Kazuteru Hatanaka, Takeshi Nishimoto, Shumpei Ohnami, Joanne T. Douglas, David T. Curiel, Teruhiko Yoshida. Direct Selection of Targeted Vector from a Random Peptide Library Displayed on Adenoviral Fiber Knob. MOLECULAR THERAPY. 2006. 13. S7-S7
- 2014/04 - 現在 Shizuoka Cancer Center, Research Institute
- 1995/05 - 2013/03 National Cancer Center
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
